Crimson Publishers Publish With Us Reprints e-Books Video articles


Perceptions in Reproductive Medicine

A Unique Birth Control Vaccine under Development

Submission: September 08, 2017;Published: November 03, 2017

DOI: 10.31031/PRM.2017.01.000503

ISSN: 2640-9666
Volume1 Issue1


Summarized here is the long journey traversed for development of a vaccine against human chorionic gonadotropin (hCG), which is safe, reversible and competent to prevent pregnancy in sexually active women without derangement of ovulation, reproductive hormones profile and menstrual regularity. A recombinant version of hCGβ linked to B subunit of heat-labile enterotoxin of E. coli, has been made and passed on to Industry for production under GMP conditions. The vaccine has received the approval of RCGM (Review Committee on Genetic Manipulation) and of the Drugs Controller General of India for clinical trials under the aegis of Indian Council of Medical Research.

Get access to the full text of this article